Opus Genetics, Inc. (NASDAQ:IRD) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On March 2, 2026, BTIG raised the price target on Opus Genetics, Inc. (NASDAQ:IRD) to $12 from $7 and ...

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or ...

When a loved one passes away, it can be an emotional experience. Unfortunately, handling the deceased’s finances can add to this stress. While most people know that you need to file a final tax return ...

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $1.27 per share a year ago. These figures ...

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs). It develops OPGx ...

Inherited retinal dystrophy (IRD) is a group of rare eye diseases. If you have IRD, you may get blurry vision, sensitivity to light, or have trouble seeing colors. Over time, you may lose some or all ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Marguerita is a Certified Financial Planner ...

CPAs MUST EXERCISE CAUTION TO CAPTURE CORRECT income in respect of the decedent (IRD) deductions on clients’ returns. Since clients typically don’t understand the issue well enough to volunteer the ...

Most tax preparers likely have heard of an IRD deduction. But since it’s less frequently claimed than many other types of deductions, many practitioners still have some questions about when and how it ...